Author name: Yali Friedman

FDA Chief Eyes Path for Copycat Biotech Drugs Food and Drug Administration Commissioner Mark McClellan said on Friday it may […]

Boston’s Biotech Moment The future is moving out of dusty library stacks and into pristine laboratories on both sides of

Boston’s Biotech Moment The future is moving out of dusty library stacks and into pristine laboratories on both sides of

Professor, Biotech Butt Heads Ignacio Chapela, an ecologist known for his controversial research on genetically modified corn, is turning a

Tech Transfer: The Ties That Bind Did you know that the lack of an IPO window, depressed market conditions and

Drug companies make patent concessions AIDS activists hailed a breakthrough agreement with two of the largest drug companies in South

Dutch Official Calls on Europe to Open Markets to Biotech Foods Europe should no longer exclude genetically modified agricultural products

Financial Snapshot For November 2003: Hangin’ In There

A dietary magic bullet? Eat, drink and be merry, for tomorrow you can throw down a Longevinex pill, the new

FDA, Industry Collaborate On Genomics Guide Last month, the FDA issued its long-awaited draft guidelines for pharmacogenomic data submission. Companies